Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity.
Saved in:
| Title: | Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. |
|---|---|
| Authors: | Gorman DM; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Li XX; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Lee JD; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Fung JN; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Cui CS; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Lee HS; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia., Rolfe BE; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia., Woodruff TM; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia., Clark RJ; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia. |
| Source: | Journal of medicinal chemistry [J Med Chem] 2021 Nov 25; Vol. 64 (22), pp. 16598-16608. Date of Electronic Publication: 2021 Nov 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34762432 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gorman+DM%22">Gorman DM</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Li+XX%22">Li XX</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+JD%22">Lee JD</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Fung+JN%22">Fung JN</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Cui+CS%22">Cui CS</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Lee+HS%22">Lee HS</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Rolfe+BE%22">Rolfe BE</searchLink>; Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Woodruff+TM%22">Woodruff TM</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia.; Queensland Brain Institute, The University of Queensland, Brisbane, Queensland 4072, Australia.<br /><searchLink fieldCode="AU" term="%22Clark+RJ%22">Clark RJ</searchLink>; School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland 4072, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229716531%22">Journal of medicinal chemistry</searchLink> [J Med Chem] 2021 Nov 25; Vol. 64 (22), pp. 16598-16608. <i>Date of Electronic Publication: </i>2021 Nov 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9716531 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-4804 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200222623%22">00222623 </searchLink><i>NLM ISO Abbreviation: </i>J Med Chem <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34762432 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acs.jmedchem.1c01174 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 16598 Titles: – TitleFull: Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gorman DM – PersonEntity: Name: NameFull: Li XX – PersonEntity: Name: NameFull: Lee JD – PersonEntity: Name: NameFull: Fung JN – PersonEntity: Name: NameFull: Cui CS – PersonEntity: Name: NameFull: Lee HS – PersonEntity: Name: NameFull: Rolfe BE – PersonEntity: Name: NameFull: Woodruff TM – PersonEntity: Name: NameFull: Clark RJ IsPartOfRelationships: – BibEntity: Dates: – D: 25 M: 11 Text: 2021 Nov 25 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 1520-4804 Numbering: – Type: volume Value: 64 – Type: issue Value: 22 Titles: – TitleFull: Journal of medicinal chemistry Type: main |
| ResultId | 1 |